Immunogen Inc (DELISTED) (IMGN:DL)
31.25
USD |
NASDAQ |
Feb 09, 16:00
Immunogen Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| AbbVie, Inc. | 456.92B |
| Pfizer Inc. | 189.39B |
| Johnson & Johnson | 529.11B |
| Merck & Co., Inc. | 273.10B |
| Cerevel Therapeutics Holdings Inc (DELISTED) | 7.683B |
Enterprise Value Related Metrics
| Gross Profit Margin (Quarterly) | 98.10% |
| Profit Margin (Quarterly) | 27.11% |